Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimebutine for Adverse Events in H. Pylori Eradication
NCT04403087Phase 4Completed
- Sponsor
- Hallym University Chuncheon Sacred Heart Hospital
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimebutine in Helicobacter pylori infection, sponsored by Hallym University Chuncheon Sacred Heart Hospital. Started May 2021; status: completed.
02
Drugs
trimebutine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04403087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04403087.